This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/domain/vavai/projekt/
n18http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n13http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F67985807%3A_____%2F02%3A06020201%21RIV%2F2003%2FAV0%2FA06003%2FN/
n16http://linked.opendata.cz/ontology/domain/vavai/
n10http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F67985807%3A_____%2F02%3A06020201%21RIV%2F2003%2FAV0%2FA06003%2FN
rdf:type
skos:Concept n16:Vysledek
dcterms:description
The aim of the study was to evaluate the efficacy and safety of disease-modifying drugs (DMARDs) in everyday clinical practice in Central European States (the Cyech and Slovak republics). This was a retrospective, multicentre study. With the help of a special questionnaire, the medical files of 760 patients in 15 centres were analysed looking for reasons for DMARD discontinuation (e.g. insufficient efficacz, toxicity). The aim of the study was to evaluate the efficacy and safety of disease-modifying drugs (DMARDs) in everyday clinical practice in Central European States (the Cyech and Slovak republics). This was a retrospective, multicentre study. With the help of a special questionnaire, the medical files of 760 patients in 15 centres were analysed looking for reasons for DMARD discontinuation (e.g. insufficient efficacz, toxicity).
dcterms:title
Analysis of the Reasons for DMARD Therapy Discountinuatin in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics. Analysis of the Reasons for DMARD Therapy Discountinuatin in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics.
skos:prefLabel
Analysis of the Reasons for DMARD Therapy Discountinuatin in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics. Analysis of the Reasons for DMARD Therapy Discountinuatin in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics.
skos:notation
RIV/67985807:_____/02:06020201!RIV/2003/AV0/A06003/N
n3:strany
22;26
n3:aktivita
n11:P n11:Z
n3:aktivity
P(NK4886), Z(AV0Z1030915)
n3:cisloPeriodika
N/A
n3:dodaniDat
n9:2003
n3:domaciTvurceVysledku
n18:3765873
n3:druhVysledku
n7:J
n3:duvernostUdaju
n4:S
n3:entitaPredkladatele
n13:predkladatel
n3:idSjednocenehoVysledku
638131
n3:idVysledku
RIV/67985807:_____/02:06020201
n3:jazykVysledku
n14:eng
n3:klicovaSlova
adverse effects; disease-modyfying drugs; DMARDs; rheumatoid arthritis; therapy
n3:klicoveSlovo
n5:therapy n5:DMARDs n5:rheumatoid%20arthritis n5:disease-modyfying%20drugs n5:adverse%20effects
n3:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n3:kontrolniKodProRIV
[C6E982869EE4]
n3:nazevZdroje
Clinical Rheumatology
n3:obor
n17:BA
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
6
n3:pocetUcastnikuAkce
0
n3:pocetZahranicnichUcastnikuAkce
0
n3:projekt
n15:NK4886
n3:rokUplatneniVysledku
n9:2002
n3:svazekPeriodika
21
n3:tvurceVysledku
Pavelka, K. Rovenský, J. Pavelková, A. Tuchyňová, A. Forejtová, Š. Zvárová, Jana
n3:zamer
n10:AV0Z1030915
s:issn
0770-3198
s:numberOfPages
7